Jeana Benwill, MD
Basic profileThe University of Texas Health Science Center at Tyler
Jeana Benwill is an Infectious Disease physician affiliated with The University of Texas Health Science Center at Tyler. OpenAlex indexes 13 publications with 720 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7030 New Sanger Ave Ste 202
Waco, TX 76712
Telephone
254-772-4400Registry record last updated 26 Jul 2018.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20258 payments
- Electromed, Inc.Program year20252 payments
- Gilead Sciences, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
96.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor23.3%Juluca50%Dovato33%Tivicay17%Part D<11 patientsFirst-generation cephalosporins13.8%Cefadroxil56%Cephalexin44%Part D≥17 patients+ 15 more classes in this area
Sensory organs
1.7%Fluoroquinolone Antibacterial1.7%Ciprofloxacin Hcl100%Part D≥14 patientsMetabolism & gastrointestinal
1.1%Proton pump inhibitor1.1%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Correction for Vasireddy et al., Mycobacterium arupense, Mycobacterium heraklionense, and a Newly Proposed Species, “Mycobacterium virginiense” sp. nov., but Not Mycobacterium nonchromogenicum, as Species of the Mycobacterium terrae Complex Causing Tenosynovitis and Osteomyelitis
Journal of Clinical Microbiology
2017 - Emergence of <i>mmpT5</i> Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease
Journal of Clinical Microbiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Idell, MD
The University of Texas Health Science Center at Tyler
Julie Philley, MD
The University of Texas Health Science Center at Tyler
James Caccitolo, MD
The University of Texas Health Science Center at Tyler
George Plotkin, MD
The University of Texas Health Science Center at Tyler
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”